Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
United European Gastroenterology Journal|March 28, 2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsSophia Heinrich, Martin Sprinzl, Irene Schmidtmann, et al.Zeitschrift Fur Gastroenterologie|January 9, 2023
Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35Julia Ortner, Reyn Joris Van Ewijk, Louis Velthuis, et al.Journal of Cancer Research and Clinical Oncology|September 19, 2014
Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!Markus Moehler, Thomas Thomaidis, Chourouk Zeifri, et al.Zeitschrift Fur Gastroenterologie|January 14, 2020
Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohortJohanna Vollmar, Franziska Stern, Karl Lackner, et al.JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.United European Gastroenterology Journal|March 8, 2018
Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic diseaseMartha M Kirstein, Torsten Voigtländer, Nora Schweitzer, et al.Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.Pageof 14